Drugs / CAR T-cell therapy
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT06649227 | Jul 2025 → Jul 2029 expected | acute myeloid leukemia | University Hospital, Lille | Recruiting | No outcome recorded |
| Phase 1 | NCT05043571 | Sep 2021 → Nov 2026 expected | adult acute lymphoblastic leukemia, childhood acute lymphoblastic leukemia | National University Hospital, Singapore | Recruiting | No outcome recorded |
| Phase 1 | NCT05038696 | Apr 2021 → May 2026 overdue | adult acute lymphoblastic leukemia, childhood acute lymphoblastic leukemia | National University Hospital, Singapore | Recruiting | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04206943 | Oct 2019 → Jan 2021 | acute lymphoblastic leukemia | Acibadem University | Unknown | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT06567366 | Sep 2024 → Sep 2027 expected | large B-cell lymphoma | Ruijin Hospital | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT04534634 | Apr 2019 → Jul 2023 | B-cell acute lymphoblastic leukemia | The First Affiliated Hospital of Soochow University | Unknown | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT06238336 | Jun 2020 → Nov 2025 | hematopoietic and lymphoid cell neoplasm | Shanxi Bethune Hospital | Unknown | No outcome recorded |
Press releases naming this drug 8 releases
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-T cell therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06649227 ↗ |
| Action | Deplete | “targeting the entire leukemia cell population to induce deeper and more durable remissions” NCT05038696 ↗ |
| Modality | Cell therapy | “Clinical trials of CAR-T cell therapy started at the end of 1990s.” NCT04206943 ↗ |
| Route | Intravenous | “intravenously infusion” NCT04534634 ↗ |
| Target | CD19 | “CD19 Specific CAR-T Cells” NCT04206943 ↗ |